The Role of Inflammation-Associated Factors in Head and Neck Squamous Cell Carcinoma
Kang Li,Xianhai Zeng,Peng Liu,Xiaoxia Zeng,Jie Lv,Shuqi Qiu,Peng Zhang
DOI: https://doi.org/10.2147/jir.s428358
IF: 4.5
2023-09-28
Journal of Inflammation Research
Abstract:Kang Li, 1, 2, &ast Xianhai Zeng, 1, 2, &ast Peng Liu, 1, 2 Xiaoxia Zeng, 2 Jie Lv, 3 Shuqi Qiu, 1, 2 Peng Zhang 1, 2 1 Department of Graduate and Scientific Research, Zunyi Medical University Zhuhai Campus, Zhuhai, Guangdong, People's Republic of China; 2 Department of Otorhinolaryngology, Longgang Otorhinolaryngology Hospital & Shenzhen Key Laboratory of Otorhinolaryngology, Shenzhen Institute of Otorhinolaryngology, Shenzhen, Guangdong, People's Republic of China; 3 School of Computer Science and Engineering, Yulin Normal University, Yulin, Guangxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shuqi Qiu; Peng Zhang, Longgang Otorhinolaryngology Hospital & Shenzhen Key Laboratory of Otorhinolaryngology, Shenzhen Institute of Otorhinolaryngology, No. 3004 Longgang Avenue, Shenzhen, Guangdong, People's Republic of China, Tel +86-755-28989999, Fax +86-755-28980505, Email ; Head and neck squamous cell carcinoma (HNSCC), which originates in the head or neck tissues, is characterized by high rates of recurrence and metastasis. Inflammation is important in HNSCC prognosis. Inflammatory cells and their secreted factors contribute to the various stages of HNSCC development through multiple mechanisms. In this review, the mechanisms through which inflammatory factors, signaling pathways, and cells contribute to the initiation and progression of HNSCC have been discussed in detail. Furthermore, the diagnostic and therapeutic potential of targeting inflammation in HNSCC has been discussed to gain new insights into improving patient prognosis. Keywords: inflammation, head and neck squamous cell carcinoma, HNSCC, mediators, progression, therapy Head and neck tumors originate from the epithelial tissues of the paranasal sinuses, nasal cavity, oral cavity, pharynx, and larynx. Head and neck squamous cell carcinoma (HNSCC) is the predominant malignancy affecting these regions, and is the sixth most common cancer worldwide, with an annual diagnosis of over 500,000 new cases. 1 The established risk factors of HNSCC include tobacco and alcohol consumption; betel nut chewing is also an established risk factor of oral cancer. 2,3 HNSCC is characterized by aggressive tumor progression, high recurrence and metastasis rates, and poor prognosis. 4 The primary treatment modalities for HNSCC are radiation therapy and chemotherapy. Despite advances in these therapies, the 5-year survival rate of Patients with HNSCC remains <50%, except for early-stage tumors. 5 The frequent diagnosis of HNSCC in the advanced stage poses significant treatment challenges. Therefore, the early diagnosis and treatment of HNSCC are critical for improving patient prognosis. In recent years, immunotherapy has emerged as a promising treatment approach for HNSCC, with beneficial outcomes in selected patients. This warrants an in-depth study of the tumor microenvironment (TME) and mechanisms of immune evasion in HNSCC. TME comprises inflammatory cells and their secreted factors that may promote tumor progression. Prolonged inflammatory stimulation and immune activation lead to chronic inflammation, which results in repetitive tissue damage and regeneration. 6 In fact, inflammation is a hallmark of cancer and an initiator of malignant transformation. More and more studies have shown that inflammatory cells, mediators, and pathways contribute to the development and immune evasion of various cancer types, including HNSCC. Therefore, exploring the molecular mechanisms through which inflammation affects HNSCC progression and metastasis is crucial to develop novel therapeutic strategies. In this review, the mechanisms underlying tumor-associated inflammation, clinical significance of inflammation-related biomarkers, and potential therapeutic approaches for HNSCC have been discussed. 7 Chronic inflammation triggers sustained tissue damage and significantly contributes to the onset and progression of head and neck tumors. Several inflammation-related mediators have been implicated in HNSCC, which are discussed in detail in the following sections (Figure 1). Figure 1 Inflammation-related mediators involved in promoting tumor progression. Interleukin (IL)-1 is a proinflammatory cytokine that instigates cellular and organ inflammation. The IL-1 family comprises 11 members, of which IL-1α, IL-1β, and the IL-1 receptor antagonist (IL-1RA) are most widely studied. IL-1 receptor family members include both the activators and inhibitors of inflammation, thereby exerting diverse effects on inflammatory processes. 8 IL-1 drives tumor pr -Abstract Truncated-
immunology